·
September 21, 2018 – A featured cover story in BioCentury Innovations spotlights the rise of China’s genomics industry, with a focus on innovative companies like Seekin Inc. that are pioneering machine learning and liquid biopsy technologies for early cancer detection. The report provides a comprehensive analysis of the competitive landscape, key technological advancements, and the regulatory environment shaping the next wave of cancer diagnostics in China.
